<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">865</article-id><article-id pub-id-type="doi">10.36691/RJA865</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Helicobacter pylori infection: regulatory role of cytokines in inflammation and allergy</article-title><trans-title-group xml:lang="ru"><trans-title>Инфекция Helicobacter pylori: регуляторная роль цитокинов при воспалении и аллергии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varyushina</surname><given-names>E A</given-names></name><name xml:lang="ru"><surname>Варюшина</surname><given-names>Елена Анатольевна</given-names></name></name-alternatives><bio xml:lang="en"><p>State Scientific Center State Research Institute of Highly Pure Biopreparations</p></bio><bio xml:lang="ru"><p>ФГУП «Государственный научно-исследовательский институт особо чистых биопрепаратов» ФМБА России</p></bio><email>elenavaryush@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Simbirtsev</surname><given-names>A S</given-names></name><name xml:lang="ru"><surname>Симбирцев</surname><given-names>А С</given-names></name></name-alternatives><bio xml:lang="en"><p>State Scientific Center State Research Institute of Highly Pure Biopreparations</p></bio><bio xml:lang="ru"><p>ФГУП «Государственный научно-исследовательский институт особо чистых биопрепаратов» ФМБА России</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Scientific Center State Research Institute of Highly Pure Biopreparations</institution></aff><aff><institution xml:lang="ru">ФГУП «Государственный научно-исследовательский институт особо чистых биопрепаратов» ФМБА России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2010-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2010</year></pub-date><volume>7</volume><issue>2</issue><issue-title xml:lang="en">NO02 (2010)</issue-title><issue-title xml:lang="ru">№02 (2010)</issue-title><fpage>13</fpage><lpage>22</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2009, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2009, Фармарус Принт Медиа</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2011-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/865">https://rusalljournal.ru/raj/article/view/865</self-uri><abstract xml:lang="en"><p>Helicobacter pylori is a Gram-negative bacterium that chronically infects the stomach of more than 50% of human population and represents the major cause of gastroduodenal pathologies. The H. pylori infection is followed by local inflammatory response in gastric mucosa and proinflammatory cytokine production, and preferably elicits a T-helper 1 (Thl) immune response. Bronchial asthma and allergic diseases are orchestrated by Th2 cytokines. A negative association between the H. pylori infection and frequency of allergic diseases was found. Investigations of possible molecular mechanisms of the association are required for research of novel strategies of prevention and treatment of allergic diseases.</p></abstract><trans-abstract xml:lang="ru"><p>Helicobacter pylori - грам-негативная бактерия, которая вызывает хроническую инфекцию более чем у 50% населения и является основной причиной заболеваний желудочно-кишечного тракта. Инфицирование Н. pylori приводит к развитию локального воспалительного ответа в слизистой оболочке желудка и продукции провоспалительных цитокинов, иммунный ответ протекает с преобладанием цитокинов, продуцируемых Т-хелперами 1-го типа (Тh1). При бронхиальной астме и аллергических заболеваниях наблюдают Тh2-опосредованный иммунный ответ. Была найдена негативная ассоциация между наличием инфекции Helicobacter pylori и развитием аллергических заболеваний. Исследования возможных молекулярных механизмов этой ассоциации являются необходимыми для поиска новых стратегий предупреждения и лечения аллергии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Helicobacter pylori</kwd><kwd>Helicobacter pylori</kwd><kwd>infection</kwd><kwd>cytokines</kwd><kwd>inflammation</kwd><kwd>allergy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инфекция</kwd><kwd>цитокины</kwd><kwd>воспаление</kwd><kwd>аллергия</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>ВарюшинаЕ.А., КозловаИ.П., Котов А.Ю., Симбирцев А.С. Продукция провоспалительных цитокинов в слизистой оболочке желудка у детей с хроническими гастродуоденальными заболеваниями при инфекции Helicobacter pylori. Рос. иммунол. журн. 2009, т. 3, № 1, с. 72-83.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Козлова И.П. Иммунологические особенности детей с Helicobacter pylori-ассоциированной гастродуоденальной патологией. Автореферат... канд. мед. наук. СПб, 2002, 22 с.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Blaser M.J., Atherton J.C. Helicobacter pylori persistence: biology and disease J. Clin. Invest. 2004, v. 113, p. 321-333.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Parsonnet J., Friedman G., Vandersteen D. et al. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 1994, v. 330, p. 1267-1271.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Smith M., Hold G., Eahara E., El-Omar E. Cellular and molecular aspects of gastric cancer. World J. Gastroenterol. 2006, v. 12, p. 2979-2990.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>CremoniniE, Gasbarrini A. Atopy, Helicobacter pylori and hygiene hypothesis. European Journal of Gastroenterology and Hepatology. 2003, v. 15, p. 635-636.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Wjst M. Does Helicobacter pylori protect against asthma and allergy. Gut. 2008, v. 57, p. 1178-1179.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Chen Y, Blaser M.J. Inverse associations of Helicobacter pylori protection with asthma and allergy. Arch. Intern. Med. 2007, v. 167, p. 821-827.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Dunn B.E., Cohen H., Blaser M.J. Helicobacter pylori. Clin. Microbiol. Reviews. 1997, v. 10, p. 720-741.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Beswick E., Suarez G., Reyes V. H. pylori and host interactions that influence pathogenesis .World J. Gastroenterol. 2006, v. 12, p. 5599-5605.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Loughlin M.F., Barnard F.M., Jenkins D.et al. Helicobacter pylori mutants defective in RuvC Holliday junction resolvase display reduced macrophage survival and spontaneous clearance from the murine gastric mucosa. Infect. Immune. 2003, v. 71, p. 2022-2031.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Rieder G., Fischer W, Rainer H. Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Current Opinion in Microbiology. 2005, v. 8, p. 67-73.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Bartchewsky W Jr., Martini M.R., Masiero M. et al. Effect of Helicobacter pylori infection on IL-8, IL-1 beta and COX-2 production in patients with chronic gastritis and gastric cancer. Scand. J. Gastroenterol. 2009, v. 44, p. 154-161.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kuipers E.J., Perez-Perez G.I., Meuwissen S.G. et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl. Cancer Inst. 1995, v. 87, p. 1777-1780.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Rieder G., FischerW, Rainer H. Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Current Opinion in Microbiology. 2005, v. 8, p. 67-73.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Amedei A., Cappon A., Codolo G. et al. The neutrophil-activating protein of Helicobacter pylori promote Th1 immune response. J. Clin. Invest. 2006, v. 116, p. 1092-1101.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Wang C.A., Liu Y.C., Du S.Y. et al. Helicobacter pylori neutrophil-activating protein promotes myeloperoxidase release from human Neutrophils. Biochem. Biophys. Res. Commun. 2008, v. 377, p. 52-56.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Codolo G., Mazzi P., Amedei A. et al. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic astma. Cell. Microbiol. 2008, v. 10, p. 2355-2363.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Portal-Celhay C, Perez-Perez G.I. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clinical Science. 2006, v. 110, p. 305-314.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Scott Algood H.M., Cover T.L. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin. Microbiol. Reviews. 2006, v. 19, p. 597-613.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Jonsson K., Guo B.P, Monstein H.J. et al. Molecular cloning and characterization of two Helicobacter pylori genes coding for plasminogen-binding proteins. Proc. Natl. Acad. Sci. USA. 2004, v. 101, p. 1852-1857.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>BamfordK., FanX., Crowe S. et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 1998, v.114, p. 482-492.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Sawai N., Kita M., Kodama T. et al. Role of g interferon in Helicobacter pylori induced gastric inflammatory responses in a mouse model. Infect. Immun. 1999, v. 67, p. 279-285.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Demi L., Aigner M., Decker J. et al. Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent. Infect. Immun. 2005, v. 73, p. 4732- 4742.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Raghavan S., Holmgren J. CD4+ CD25+ suppressor T cell regulate pathogen induced inflammation and disease. FEMS Immunol. Medical Microbiol. 2005, v. 44, p. 121-127.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Graham D., Opekun A., Osato M. et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004, v. 53, p. 1235-1243.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>D'Elios M.M., Amadei A., Benagiano M. et al. Helicobacter pylori, T cells and cytokines: the «dangerous liaisons». FEMS Immunol. Med. Microbiol. 2005, v. 1. p. 113-119.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Lindholm C, Quiding-Jarbrink M., Lonroth H. et al. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 1998, v. 66, p. 5964-5971.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Luzza F, Parrello T, Monteleone G. et al. Up-regulation of IL-17 is assiciated withbioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 2000, v. 165, p. 5332-5337.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Caruso R., Fina D., Paoluzi OA. et al. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur. J. Immunol. 2008, v. 38, p. 470-478.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>El-Omar E. The importance of interleukin-lb in Helicobacter pylori associated disease. Gut. 2001, v. 48, p. 743-747.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Bhattacharyya A., Pathak S., Datta S. et al. Mitogen-activated protein kinases and nuclear factor-kB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages. Biochem. J. 2002, v. 8, p. 121-129.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Innocenti M., Svennerholm A.-M., Quiding-Jarbrink M. Helicobacter pylori lipopolisaccharides preferentially induce CXC chemokine production in human monocytes. Infection and Immunity. 2001, v. 69, p. 3800-3808.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Basso D., Scringer M., Toma A., Navaglia F et al. Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleu-kin-6, and the soluble receptor of interleukin-2. Int. J. Clin. Lab. Res. 1996, v. 26, p. 207-210.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Bodger K., Wyatt J.I., Heatley R.V. Gastric mucosal secretion of interleukin-10: relations to histopathology Helicobacter pylori status, and tumor necrosis factor-alpha secretion. Gut. 1997, v. 40, p. 739-744.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Crabtree J., Wyatt J., Trejdosiewicz L. et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gas-troduodenal mucosa. J. Clin. Path. 1994, v. 47, p. 61-66.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Katagiri M., Asaka M., Kobayashi M. et al. Increased cytokine production by gastric mucosa in patients with Helicobacter pylori infection. J. Clin. Gastroenterol. 1997, v. 25, Suppl. 1, p. 211-214.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Yamaoka Y, Kita M., Sawai N. et al. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut. 1997, v. 41, p. 442-451. 17.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Rad R., Dossumbekova A., Neu B. et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut. 2004, v. 53, p. 1082-1089.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Bayraktaroglu Т., Sukru Aras A., Aydemyr S. et al. Serum levels of tumor necrosis factor-a, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis. Mediators of Inflammation. 2004, v. 13, p. 25-28.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Rad R., Prinz C, Neu B. et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological in the gastric mucosa. J. Infect. Dis. 2003, v. 188, p. 271-281.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Xuan J., Deguchi R., Watanabe S. et al. Relationship between IL-lbeta gene polymorphism and gastric mucosal IL-lbeta levels in patients with Helicobacter pylori infection. J. Gastroenterol. 2005, v. 40, p. 796-801.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Takashima M., FuritaT., Hanai H. et al. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut. 2001, v. 48, p. 765-773.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Togawa S., Joh T., Itoh M. et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric athrophy from Helicobacter pylori infection. Helicobacter. 2005, v. 10, p. 172-178.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Pessi Т., Virta M., Adjers K. et al. Genetic and environmental factors in the immunopathogenesis of atopy: interaction of Helicobacter pylori infection and IL-4 genetics. Int. Arch. Allergy Immunol. 2005, v. 137, p. 282-288.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Oderda G., Vivenza D., Rapa A. et al. Increased interleukin-10 in Helicobacter pylori infection could be involved in the mechanism protecting from allergy. J. Pediatr. Gastroenterol. Nutr. 2007, v. 45, p. 301-305.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Atherton J.C., Blaser M. Coadaptation of Helicobacter pylori and humans: ancient history, modern implication. J. Clin. Invest. 2009, v. 119, p. 2475-2487.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Robinson K. et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut. 2008, v. 57, p. 1375-1385.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>D'Elios M.M., Codolo G., Amedei A. et al. Helicobacter pylori, asthma and allergy. FEMS Immunol. Med. Microbiol. 2009, v. 56, p. 1-8.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Yamamura F, Yoshikawa N., Akita Y. et al. Relationship between Helicobacter pylori infection and histological features of gastritis in biopsy specimens in gastroduodenal diseases, including eve-luation of diagnosis by polymerase chain reaction assay. J. Gastroenterol. 1999, v. 34, p. 461-466.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Alvarez-Arellano L., Camorlinga-Ponce M., Maldonado-Bernal C., Torres J. Activation of human neutrophils with Helicobacter pylori and the role of Toll-like receptors 2 and 4 in the response. FEMS Immunol. Med. Microbiol. 2007, v. 51, p. 473-479.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Crabtree J.E., Kersulyte D., Hernandez V. et al. Helicobacter pylori induction of IL-8 synthesis in gastric epithelial cells depends on genes throughout the cag pathogenisity island [abstract]. Gut. 1997, v. 40 (suppl. 1), p. 69.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Schmausser В., Josenhans C, Endrich S. et al. Down regulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection? Infection and Immunity. 2004, v. 72, p. 6773-6779.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Berstad A., Brandtzaeg P, Stave R. etal. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut. 1997, v. 40, p. 196-203.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Whitney A.E., Guarner J., HutwagnerL., GoldB.D. Helicobacter pylori gastritis in children and adults: comparative histopathologic study. Ann. Diagn. Pathol. 2000, v. 5, p. 279-285.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Dzierzanowska-Fangrat K., Raeiszadeh M., Dzierzanowska D. et al. IgG subclass response to Helicobacter pylori and Cag A antigens in children. Clin. Exp. Immunol. 2003, v. 134, p. 442-446.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Maciorkowska E., Panasiuk A., Kaczmarski M. Concentrations of gastric mucosal cytokines in children with food allergy and Helicobacter pylori infection. World J. Gastroenterol. 2005, v. 11, p. 6751-6756.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Dzierzanowska-Fangrat K., Michalkiewicz J., Cielecka-Kuszyk J. etal. Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infiltration, IL-8, and IL-1 beta mRNA expression. Eur. J. Gastroene-trol. Hepatol. 2008, v. 20, p. 314-319.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Harris P.R. et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology. 2008, v. 134, p. 491-499.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Shimizu T, Haruna H., Ohtsuka Y et al. Cytokines in the gastric mucosa of children with Helicobacter pylori infection. Acta Paediatr. 2004, v. 93, p. 322-326.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Bontems P., Robert F, Van Gossum A., Cadranel S., Mascart F Helicobacter pylori modulation of gastric and duodenal mucosal T cell cytokines secretions in children compared with adults. Helicobacter. 2003, v. 8, p. 216-226.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Lopes A.I., Quiding-Jarbrink M., Palha A. et al. Cytokine expression in pediatric Helicobacter pylori infection. Clinical and Diagnostic Laboratory Immunology. 2005, v. 12, p. 994-1002.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Queiroz D., Bittencourt P., Guerra J. et al. IL-11RN polymorphism and cagA-positive Helicobacter pylori strains increase the risk of duodenal ulcer in children. Pediatr. Res. 2005, v. 58, p. 892-896.</mixed-citation></ref></ref-list></back></article>
